NCT04646707 Effect of Erector Spinae (ESP) Block on Opioid Reduction and Enhanced Recovery After Posterior Cervical Spine Surgery
| NCT ID | NCT04646707 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Health Network, Toronto |
| Condition | Postoperative |
| Study Type | INTERVENTIONAL |
| Enrollment | 52 participants |
| Start Date | 2020-02-17 |
| Primary Completion | 2025-12-17 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 52 participants in total. It began in 2020-02-17 with a primary completion date of 2025-12-17.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients undergoing spine surgery frequently experience significant pain after surgery. This can limit patient activity and hinder rehabilitation. If inadequately treated, severe pain can result in emotional and psychological distress and ultimately impact long-term function, and increase the risk of developing pain that lasts longer than six months associated with depression, anxiety and disability. More specifically, Erector Spinae Plane (ESP) block is a recently described plane block designed to block the dorsal and ventral rami of the thoracic spinal nerves. It has shown to be an effective modality for postoperative pain management as a part of multimodal analgesia in spinal surgery.
Eligibility Criteria
Inclusion Criteria: All adult patients aged 18-80 years with ASA class I - III undergoing posterior cervical (C3-T2) decompression and instrumented fusion for cervical stenosis in prone position. Exclusion Criteria: 1. In patients who are allergic to local anesthetics. 2. ASA IV patients 3. Lack of informed consent 4. Pregnant patient. 5. Fracture cervical spine 6. Extradural or intradural cervical tumors 7. Surgery of C1 and C2 spine
Contact & Investigator
Michael Dinsmore, MD
PRINCIPAL INVESTIGATOR
University Health Network, Toronto
Frequently Asked Questions
Who can join the NCT04646707 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Postoperative. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04646707 currently recruiting?
Yes, NCT04646707 is actively recruiting participants. Contact the research team at michael.dinsmore@uhn.ca for enrollment information.
Where is the NCT04646707 trial being conducted?
This trial is being conducted at Toronto, Canada.
Who is sponsoring the NCT04646707 clinical trial?
NCT04646707 is sponsored by University Health Network, Toronto. The principal investigator is Michael Dinsmore, MD at University Health Network, Toronto. The trial plans to enroll 52 participants.